Dear Client,
As part of our ongoing commitment to ensuring the security of your online trading experience, we would like to inform you of our protocol for addressing any suspicious activities observed on your trading account
Should you notice any irregularities or suspect unauthorized access to your account, we kindly request that you take immediate action by following the steps outlined below:
Send an Email Please send an email to stoptrade@acml.in from your registered email ID. In the email, briefly outline the suspicious activity you have observed.
Phone Call Alternatively, you can call us at 07965081981 Ext: 4 from your registered mobile number. This will enable us to address your concerns promptly.
When contacting us, please ensure you provide the following details:
By providing this information, you enable us to swiftly investigate and take appropriate measures to safeguard your account.
Your security and peace of mind are of utmost importance to us, and we appreciate your cooperation in maintaining the integrity of your trading account.
Glenmark Pharmaceuticals Ltd announced credit rating actions from India Ratings and Research, which affirmed its IND AA+ rating with a stable outlook for its Bank Loans and also rated Additional Loans, though specific details regarding the Additional Loans rating were not provided. India Ratings, alongside India Ratings and Research, provided limited information regarding Glenmark’s instruments, with no rating information found for any other instruments; the rating rationale from India Ratings and Research is enclosed, and no enhancements, assignments, or withdrawals were noted across any of the reviewed instruments.